Engineering services provider Acromec debuts on the Catalist

It will use the funds to fuel expansion.

Acromec, a Singapore-based company that specialises in the design and construction of facilities requiring controlled environments, launched its initial public offering (IPO) on the Catalist on April 18.

The company primarily serves the healthcare, biomedical, research and academia, and electronics sectors, and counts Singapore General Hospital, Agency for Science, Technology and Research (A*STAR), National University of Singapore, Procter & Gamble and Johnson Matthey Singapore, amongst its clients.

“With two decades of experience in the provision of integrated specialist engineering solutions within controlled environments, Acromec has built up an established track record in Singapore. Our listing on the Catalist is timely, planned at a time when we are forging ahead with strategies to scale up our operations in Singapore and also expand our horizons into the emerging ASEAN region,” said Lim Say Chin, Executive Chairman and Managing Director of Acromec.

Acromec will trade under the stock code 43F. Its listing brings the total number of companies on Catalist to 178, with a combined market capitalisation of S$9 billion. 

Join Singapore Business Review community
Since you're here...

...there are many ways you can work with us to advertise your company and connect to your customers. Our team can help you dight and create an advertising campaign, in print and digital, on this website and in print magazine.

We can also organize a real life or digital event for you and find thought leader speakers as well as industry leaders, who could be your potential partners, to join the event. We also run some awards programmes which give you an opportunity to be recognized for your achievements during the year and you can join this as a participant or a sponsor.

Let us help you drive your business forward with a good partnership!